Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seng Gee Lim

Showing results (211-220 of 241) with videos related to

Pageof 25
Sort By:
Hepatology International|September 10, 2010
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinomaMasao Omata, Laurentius A Lesmana, Ryosuke Tateishi, et al.
Gut|April 1, 2018
Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapyYue Zhao, Timothy Wai Ho Shuen, Tan Boon Toh, et al.
Frontiers in Immunology|October 5, 2020
CD4<sup>+</sup> T Cells Mediate the Development of Liver Fibrosis in High Fat Diet-Induced NAFLD in Humanized MiceZhisheng Her, Joel Heng Loong Tan, Yee-Siang Lim, et al.
Immunity|July 16, 2021
Non-terminally exhausted tumor-resident memory HBV-specific T cell responses correlate with relapse-free survival in hepatocellular carcinomaYang Cheng, Bavani Gunasegaran, Harsimran D Singh, et al.
Hepatology (Baltimore, Md.)|March 11, 2021
Treatment and Renal Outcomes Up to 96 Weeks After Tenofovir Alafenamide Switch From Tenofovir Disoproxil Fumarate in Routine PracticeHidenori Toyoda, Jennifer Leong, Charles Landis, et al.
Hepatology International|October 8, 2016
Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 updateGamal Shiha, Alaa Ibrahim, Ahmed Helmy, et al.
Nature Communications|March 28, 2020
A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinomaLi Ren Kong, Nur Afiqah Binte Mohamed Salleh, Richard Weijie Ong, et al.
Gastroenterology|October 11, 2015
Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis BPatrick Marcellin, Sang Hoon Ahn, Xiaoli Ma, et al.
The New England Journal of Medicine|November 8, 2022
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B InfectionMan-Fung Yuen, Seng-Gee Lim, Robert Plesniak, et al.
Journal of Hepatology|June 17, 2022
Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapyMan-Fung Yuen, Jeong Heo, Hiromitsu Kumada, et al.
Pageof 25

Showing results (211-220 of 241) with videos related to

Sort By:
Pageof 25
Hepatology International|September 10, 2010
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinomaMasao Omata, Laurentius A Lesmana, Ryosuke Tateishi, et al.
Gut|April 1, 2018
Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapyYue Zhao, Timothy Wai Ho Shuen, Tan Boon Toh, et al.
Frontiers in Immunology|October 5, 2020
CD4<sup>+</sup> T Cells Mediate the Development of Liver Fibrosis in High Fat Diet-Induced NAFLD in Humanized MiceZhisheng Her, Joel Heng Loong Tan, Yee-Siang Lim, et al.
Immunity|July 16, 2021
Non-terminally exhausted tumor-resident memory HBV-specific T cell responses correlate with relapse-free survival in hepatocellular carcinomaYang Cheng, Bavani Gunasegaran, Harsimran D Singh, et al.
Hepatology (Baltimore, Md.)|March 11, 2021
Treatment and Renal Outcomes Up to 96 Weeks After Tenofovir Alafenamide Switch From Tenofovir Disoproxil Fumarate in Routine PracticeHidenori Toyoda, Jennifer Leong, Charles Landis, et al.
Hepatology International|October 8, 2016
Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 updateGamal Shiha, Alaa Ibrahim, Ahmed Helmy, et al.
Nature Communications|March 28, 2020
A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinomaLi Ren Kong, Nur Afiqah Binte Mohamed Salleh, Richard Weijie Ong, et al.
Gastroenterology|October 11, 2015
Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis BPatrick Marcellin, Sang Hoon Ahn, Xiaoli Ma, et al.
The New England Journal of Medicine|November 8, 2022
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B InfectionMan-Fung Yuen, Seng-Gee Lim, Robert Plesniak, et al.
Journal of Hepatology|June 17, 2022
Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapyMan-Fung Yuen, Jeong Heo, Hiromitsu Kumada, et al.
Pageof 25